RxDoctor Payments Data

Katina Smith

Adult Health · Saint Louis, MONPI 1245896893

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,030 of the $9,129 with a category attached, or 77.0%. 23 manufacturers reported payments, led by Calliditas Therapeutics US Inc. at 25.6% of the total. 2025 is the largest year on record at $4,090, 6.8 times the $604 reported in 2021. Among adult health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,129in general payments, 2019–2025

Across 265 payments — averaging $34.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Calliditas Therapeutics US Inc.$2K
  • AstraZeneca$1K
  • Amgen$1K
  • GSK$592
  • Vifor Pharma, Inc.$516
  • Travere Therapeutics, Inc.$454
  • plus $3K from 17 others

What the payments were for

  • Consulting fees$2,03122%
  • Food & beverage$7,03077%
  • Education$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,129 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide13$62,249
Midodrine Hcl13$806
Lidocaine-PrilocaineLidocaine/Prilocaine23$760
Losartan Potassium15$290
Metoprolol Succinate14$212
Carvedilol15$139
Amlodipine Besylate17$116
Hydralazine Hcl12$105
Prednisone12$52
Furosemide12$26

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$115$62,24913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 555 adult health providers in Missouri.

Other adult health in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →